Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J SMALL

Showing results (1021-1030 of 1,203) with videos related to

Pageof 121
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer TypesWilliam S Chen, Mohammed Alshalalfa, Shuang G Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancerW K Kelly, T Curley, S Slovin, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 10, 2022
An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer StudyDanielle B Tometich, Catherine E Mosher, Melissa Cyders, et al.
Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancerMatthew R Smith, Fairooz Kabbinavar, Fred Saad, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 1997
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone releaseC J Small, D G Morgan, K Meeran, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
European Urology|March 19, 2017
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Matthew R Smith, Fred Saad, Dana E Rathkopf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of the National Cancer Institute|January 23, 2021
Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer StudyJeanne S Mandelblatt, Xingtao Zhou, Brent J Small, et al.
Pageof 121

Showing results (1021-1030 of 1,203) with videos related to

Sort By:
Pageof 121
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer TypesWilliam S Chen, Mohammed Alshalalfa, Shuang G Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancerW K Kelly, T Curley, S Slovin, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 10, 2022
An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer StudyDanielle B Tometich, Catherine E Mosher, Melissa Cyders, et al.
Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancerMatthew R Smith, Fairooz Kabbinavar, Fred Saad, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 1997
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone releaseC J Small, D G Morgan, K Meeran, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
European Urology|March 19, 2017
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Matthew R Smith, Fred Saad, Dana E Rathkopf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of the National Cancer Institute|January 23, 2021
Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer StudyJeanne S Mandelblatt, Xingtao Zhou, Brent J Small, et al.
Pageof 121